C-Path and CDISC announce breakthrough in TB drug development tools

Tucson, AZ - 10 September 2012 – Critical Path Institute and CDISC (Clinical Data Interchange Standards Consortium) announce the availability of a breakthrough tool to help combat tuberculosis (TB)—a persistent disease resulting in 1.7 million deaths globally each year.